Daiwa Securities Group Inc. lifted its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 10.0% ...

Valued at $29.1 billion by market cap, California-based Deckers Outdoor Corporation (DECK) stands tall as a global powerhouse ...

Teva's reasonable valuation, an improving pipeline, and sales and profit growth potential are good enough reasons for those ...

Generic and biosimilar drugs are often preferred over the brand name version due to their cheaper prices. Generics are exact ...

Corcept Therapeutics specializes in cortisol-modulating drugs. Click here to read why CORT stock offers investment potential.

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has received a consensus recommendation of “Moderate Buy ...

EW STOCK REPORT: Suffer Losses On Your Edwards Lifesciences Investment? Contact BFA Law About The Pending Class Action Lawsuit (NYSE:EW) ...

As a result of the news, Elanco's stock price declined over 21%, from $17.97 per share on June 26, 2024 to $14.27 per share on June 27, 2024. BFA Law is investigating whether Elanco and certain of its ...

MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced ...

The management anticipates stronger performance in the coming quarters due to the company's upcoming new launches, the onset ...

With an average analyst rating of buy, Teva Pharmaceutical Industries is clearly an analyst favorite. But the analysts could ...

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA fell 1.73%, and Camtek (Nasdaq: CAMT; TASE: CAMT) fell 3.80% for the biggest fall on the Tel Aviv 35 Index today. Outside of the Tel Aviv 35 ...